Hematopoietic stem cells: Phase I ongoing

FDA lifted its clinical hold on a Phase I trial. The trial was stopped after 2 cases of grade IV acute graft-versus-host disease (GVHD) were seen in 8 patients treated with CB001 (see BioCentury, Sept...